Comparison Between Different Horizontal Ridge Augmentation Techniques
NCT ID: NCT06176417
Last Updated: 2023-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2021-08-26
2023-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients' grouping:
Patients were divided randomly into two equal uniform groups as follow:
Group I:
Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by decompression technique.
Group II:
Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by ridge splitting technique using piezosurgery.
All patients were evaluated clinically and radiographically at regular time interval immediately, 6 and 12 months after surgery.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1
Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by decompression technique.
horizontal ridge augmentation by decompression technique.
Instead of a cover screw, a 2-mm healing abutment was used after implant insertion
group 2
Eight implants were placed in patients of missing single tooth / teeth in posterior mandible with subsequent horizontal ridge augmentation by ridge splitting technique using piezosurgery.
horizontal ridge augmentation by ridge splitting technique using piezosurgery.
horizontal ridge augmentation was done using piezosurgery tips and bone expanders
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
horizontal ridge augmentation by decompression technique.
Instead of a cover screw, a 2-mm healing abutment was used after implant insertion
horizontal ridge augmentation by ridge splitting technique using piezosurgery.
horizontal ridge augmentation was done using piezosurgery tips and bone expanders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient medically free from systemic diseases that absolutely contraindicate implant surgery.
* Moderately atrophic posterior mandible (horizontal alveolar dimension is not more than 4 mm at the crest), with minimum 10 mm vertical height.
* Patients prepared to comply with the follow-up and maintenance programme.
* Free from history of bruxism / parafunctional habits.
Exclusion Criteria
* Pregnant patients.
* Heavy smoker patients.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara elmaghraby
assistant lecturer of oral and maxillofacial surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sara Elmagraby
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A03030821
Identifier Type: -
Identifier Source: org_study_id